Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized Study.
Olanow CW, Espay AJ, Stocchi F, Ellenbogen AL, Leinonen M, Adar L, Case RJ, Orenbach SF, Yardeni T, Oren S, Poewe W; 006 study group. Olanow CW, et al. Among authors: oren s. J Parkinsons Dis. 2021;11(1):177-186. doi: 10.3233/JPD-202285. J Parkinsons Dis. 2021. PMID: 33164945 Free PMC article. Clinical Trial.
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND Study.
Poewe W, Stocchi F, Arkadir D, Ebersbach G, Ellenbogen AL, Giladi N, Isaacson SH, Kieburtz K, LeWitt P, Olanow CW, Simuni T, Thomas A, Zlotogorski A, Adar L, Case R, Oren S, Fuchs Orenbach S, Rosenfeld O, Sasson N, Yardeni T, Espay AJ; BeyoND study group. Poewe W, et al. Among authors: oren s. Mov Disord. 2021 Nov;36(11):2687-2692. doi: 10.1002/mds.28758. Epub 2021 Sep 8. Mov Disord. 2021. PMID: 34496081 Free PMC article.
ND0701, A Novel Formulation of Apomorphine for Subcutaneous Infusion, in Comparison to a Commercial Apomorphine Formulation: 28-Day Pharmacokinetic Study in Minipigs and a Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Relative Bioavailability.
Ramot Y, Nyska A, Adar L, Durlach C, Fishelovitch D, Sacco G, Manno RA, Oren S, Perlstein I, Yacobi-Zeevi O. Ramot Y, et al. Among authors: oren s. CNS Drugs. 2018 May;32(5):443-454. doi: 10.1007/s40263-018-0512-x. CNS Drugs. 2018. PMID: 29637529 Clinical Trial.
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.
Elmer L, Schwid S, Eberly S, Goetz C, Fahn S, Kieburtz K, Oakes D, Blindauer K, Salzman P, Oren S, Prisco UL, Stern M, Shoulson I; Parkinson Study Group TEMPO; PRESTO Investigators. Elmer L, et al. Among authors: oren s. J Neurol Sci. 2006 Oct 25;248(1-2):78-83. doi: 10.1016/j.jns.2006.05.014. Epub 2006 Jul 7. J Neurol Sci. 2006. PMID: 16828804 Clinical Trial.
Bronchoscopic deployment and implantation of Diffusing alpha-emitters Radiation Therapy into the lung and mediastinum for treatment of lung cancer: a pre-clinical safety and feasibility study.
Sadoughi A, Sarkar A, Novotney C, Chan C, Moreno G, Oren S, Moss L, Aharoni K, Bari SE, Edery N, Ohri N. Sadoughi A, et al. Among authors: oren s. Transl Lung Cancer Res. 2024 Jan 31;13(1):60-75. doi: 10.21037/tlcr-23-639. Epub 2024 Jan 29. Transl Lung Cancer Res. 2024. PMID: 38404993 Free PMC article.
128 results